Daiichi Sankyo snaffles first ripe fruit of ArQule research collaboration
This article was originally published in Scrip
Executive Summary
Some three years after it entered into the collaboration, Daiichi Sankyo has reaped the first rewards of a basic research alliance with ArQule to identify novel kinase inhibitors for cancer.